科学图书馆
-
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trialOldgren J, Steg PG, Hohnloser SH et al. -
Extracellular Vesicles From Epicardial Fat Facilitate Atrial FibrillationO Shaihov-Teper, E Ram, N Ballan et al.
-
Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 TrialTA Zelniker, M Ardissino, F Andreotti et al.
-
Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the WeekS Kumar, E Lim, A Covic et al.
-
Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) TrialVY Reddy, SK Doshi, PROTECT AF Investigators et al.
-
Early Rhythm-Control Therapy in Patients with Atrial FibrillationP Kirchhof, AJ Camm, EAST-AFNET 4 Trial Investigators et al.
-
Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart AssociationNoseworthy PA, American Heart Association Council on Clinical Cardiology Electrocardiography and Arrhythmias Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and Stroke Council.
-
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trialP Vranckx, M Valgimigli, A Goette et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
